EDAP TMS S.A. (EDAP)
NASDAQ: EDAP · Real-Time Price · USD
3.194
-0.016 (-0.49%)
Sep 13, 2024, 10:01 AM EDT - Market open
EDAP TMS Revenue
EDAP TMS had revenue of 15.79M EUR in the quarter ending June 30, 2024, with 10.59% growth. This brings the company's revenue in the last twelve months to 62.05M, up 8.79% year-over-year. In the year 2023, EDAP TMS had annual revenue of 60.42M with 9.64% growth.
Revenue (ttm)
62.05M EUR
Revenue Growth
+8.79%
P/S Ratio
1.79
Revenue / Employee
202,107 EUR
Employees
307
Market Cap
118.52M USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 60.42M | 5.31M | 9.64% |
Dec 31, 2022 | 55.11M | 11.04M | 25.06% |
Dec 31, 2021 | 44.07M | 2.40M | 5.77% |
Dec 31, 2020 | 41.66M | -3.25M | -7.24% |
Dec 31, 2019 | 44.91M | 5.73M | 14.62% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
American Well | 254.91M |
Quipt Home Medical | 244.23M |
Assertio Holdings | 132.19M |
Repare Therapeutics | 68.68M |
908 Devices | 52.69M |
Inventiva | 25.60M |
Myomo | 21.11M |
Sagimet Biosciences | 2.00M |
EDAP News
- 15 days ago - EDAP to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire
- 15 days ago - EDAP TMS S.A. (EDAP) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 16 days ago - EDAP Reports Second Quarter 2024 Financial Results - GlobeNewsWire
- 5 weeks ago - EDAP to Announce Second Quarter 2024 Financial Results on August 28, 2024 - GlobeNewsWire
- 7 weeks ago - EDAP Announces Interim Results from Phase 3 Study Evaluating Robotic HIFU for the Treatment of Deep Infiltrating Endometriosis - GlobeNewsWire
- 3 months ago - EDAP Appoints New Executive Leaders to Strengthen Europe and Middle East Commercial Operations - GlobeNewsWire
- 4 months ago - EDAP TMS (EDAP) Q1 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - EDAP Announces Positive Final Results from the HIFI Study Comparing Outcomes of Focal One® HIFU Versus Radical Prostatectomy During Plenary Session at the 119th American Urological Association (AUA) Annual Meeting - GlobeNewsWire